BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14573360)

  • 1. Apoptosis: target for novel drugs.
    Alam JJ
    Trends Biotechnol; 2003 Nov; 21(11):479-83. PubMed ID: 14573360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches and therapeutics targeting apoptosis in disease.
    Fischer U; Schulze-Osthoff K
    Pharmacol Rev; 2005 Jun; 57(2):187-215. PubMed ID: 15914467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development.
    Kreuter M; Langer C; Kerkhoff C; Reddanna P; Kania AL; Maddika S; Chlichlia K; Bui TN; Los M
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):141-55. PubMed ID: 15247881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel targeted pro-apoptotic agents for the treatment of prostate cancer.
    Huang X; Zhang X; Farahvash B; Olumi AF
    J Urol; 2007 Nov; 178(5):1846-54. PubMed ID: 17868738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and diseases: regulation and clinical relevance.
    Alenzi FQ
    Saudi Med J; 2005 Nov; 26(11):1679-90. PubMed ID: 16311648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
    Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M
    Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
    Katsman A; Umezawa K; Bonavida B
    Drug Resist Updat; 2007; 10(1-2):1-12. PubMed ID: 17306602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
    O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
    Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.
    Henson ES; Gibson SB
    Cell Signal; 2006 Dec; 18(12):2089-97. PubMed ID: 16815674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
    Perego P; Cossa G; Zuco V; Zunino F
    Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial infarction and heart failure: role of apoptosis.
    Abbate A; Bussani R; Amin MS; Vetrovec GW; Baldi A
    Int J Biochem Cell Biol; 2006; 38(11):1834-40. PubMed ID: 16781883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
    Kostanová-Poliaková D; Sabová L
    Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis modulators as cancer therapeutics.
    Penn LZ
    Curr Opin Investig Drugs; 2001 May; 2(5):684-92. PubMed ID: 11569948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of apoptotic pathways triggered by cytotoxic agents.
    Solary E; Plenchette S; Sordet O; Rébé C; Ducoroy P; Filomenko R; Bruey JM; Droin N; Corcos L
    Therapie; 2001; 56(5):511-8. PubMed ID: 11806287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
    de Bruin EC; Medema JP
    Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
    Qiao L; Wong BC
    Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart.
    Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.